Literature DB >> 9649707

Pathogenesis of leukocytoclastic vasculitis.

A Claudy1.   

Abstract

There is compelling animal and human experimental evidence that leukocytoclastic vasculitis is a hypersensitivity vasculitis, similar in nature to the experimental Arthus reaction. The immune complexes formed in antigen excess circulate until some event occurs that cause deposition in blood vessel walls. Adhesion molecules and cytokines released by endothelial cells and activated neutrophils represent a key factor in this process. The membrane attack complex of complement plays a significant role in altering the endothelial cell membrane integrity. Activated neutrophils release proteolytic enzymes, especially collagenases and elastases, along with free oxygen radicals that damage the vessel walls and the surrounding tissues. It remains uncertain whether antineutrophilic cytoplasmic antibodies, anti-endothelial antibodies and anti-cardiolipin antibodies are epiphenomena or are directly involved in the disease process. Apoptotic cell death mediated by the Fas/Bc12 system is a feature of leucocytoclastic vasculitis. In conclusion, the post-capillary venule is the active orchestrator of neutrophils in leukocytoclastic vasculitis which mediate a complex series of endothelial/leukocyte interactions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649707

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  12 in total

1.  Orbital inflammatory pseudotumor due to hypersensitivity vasculitis and mononeuritis multiplex in a patient with atypical, cANCA-positive Wegener's granulomatosis.

Authors:  Jörg Kaufmann; Eberhard Schulze; Ulrich Voigt; Jürgen Strobel; Gert Hein; Günter Stein
Journal:  Rheumatol Int       Date:  2003-04-17       Impact factor: 2.631

Review 2.  My approach to superficial inflammatory dermatoses.

Authors:  K O Alsaad; D Ghazarian
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

3.  Leukocytoclastic Vasculitis Mimicking Henoch-Schönlein Purpura Preceding Onset of Ulcerative Colitis in a Child.

Authors:  Sunil V Kapur; Jitendra S Oswal
Journal:  Indian J Pediatr       Date:  2021-02-16       Impact factor: 1.967

4.  Annular leukocytoclastic vasculitis in a patient with ulcerative colitis.

Authors:  Jong Soo Hong; Seon Pil Jin; Mira Choi; Kook Lae Lee; Jong Hee Lee; Soyun Cho
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

Review 5.  Amiodarone-induced cutaneous leukocytoclastic vasculitis: a case report and a review of the literature.

Authors:  Tumay Ak; Rumeysa Nur Algan; Senay Agirgol; Seyhan Ozakkayunlu Hascicek; Zafer Turkoglu
Journal:  Clin Rheumatol       Date:  2022-06-02       Impact factor: 3.650

6.  Blocking von Willebrand factor for treatment of cutaneous inflammation.

Authors:  Carina Hillgruber; Annika K Steingräber; Birgit Pöppelmann; Cécile V Denis; Jerry Ware; Dietmar Vestweber; Bernhard Nieswandt; Stefan W Schneider; Tobias Goerge
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

7.  Delayed leucoencephalopathy after coil embolisation of unruptured cerebral aneurysm.

Authors:  Yoshihisa Fukushima; Ichiro Nakahara
Journal:  BMJ Case Rep       Date:  2018-06-23

Review 8.  Recent advances in Extracellular Vesicles and their involvements in vasculitis.

Authors:  Nan Yang; Yin Zhao; Xiuhua Wu; Na Zhang; Haoming Song; Wei Wei; Ming-Lin Liu
Journal:  Free Radic Biol Med       Date:  2021-05-02       Impact factor: 8.101

9.  Leukocytoclastic vasculitis in an adolescent with ulcerative colitis: Report of a case and review of the literature.

Authors:  G Tyler Butts; Phyllis R Bishop; Julie P Wyatt; Michael J Nowicki
Journal:  SAGE Open Med Case Rep       Date:  2014-08-20

10.  Gemcitabine-induced skin necrosis.

Authors:  Maria Monica Haydock; Saroj Sigdel; Toni Pacioles
Journal:  SAGE Open Med Case Rep       Date:  2018-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.